[Pharmacology of butylmalonic acidmono-(1,2-diphenylhydrazide)-calcium (bumadizone-calcium)].
D000700:Analgesics / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002415:Cats; D004487:Edema / Q000188:drug therapy; D005260:Female; D005334:Fever / Q000188:drug therapy; D006099:Granuloma / Q000188:drug therapy; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D007213:Indomethacin / Q000627:therapeutic use; D008297:Male; D008314:Malonates / Q000494:pharmacology* / Q000627:therapeutic use; D051379:Mice; D009161:Mycobacterium; D010113:Oxyphenbutazone / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D010659:Phenylhydrazines / Q000494:pharmacology* / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D008314:Malonates; D010659:Phenylhydrazines; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D007213:Indomethacin
Zur Pharmakologie von Butyl-malonsäure-mono-(1,2-diphenyl-hydrazid)-Calcium (Bumadizon-Calcium.